They also analyzed an independent set of 153 squamous cell carcinomas utilizing an 8p12-specific FISH probe and detected FGFR1 amplification (defined as >9 copies in an unspecified fraction of cells) in 22% of patients. This evidence concerns the gene FGFR1 and squamous cell carcinoma.